China SXT Pharmaceuticals, Inc. SXTC
At closeNov 4, 2026, 7:33 PM EST
After hours · Nov 4, 7:33 PM ET
- YTD
- -100.00%
- 1 year
- -100.00%
- Market cap
- 308.65K
- Revenue (ttm)
- 1.93M
- Profit margin
- -160.67%
- EPS (ttm)
- -73,040.00
- Shares out
- 4.06M
- YTD return
- -100.00%
- 1-year return
- -100.00%
- Volume
- 127.27K
- Avg volume
- 225.28K
- Open
- 2.85
- Previous close
- 2.88
- Day's range
- 2.84 – 3.40
- 52-week range
- 2.71 – 8,376,000.00
- Beta
- 1.16
5D -0.50 (-14.20%)
Key statistics
- Enterprise value
- -7.26M
- PEG ratio
- 0.00
- Price / sales
- 0.73
- Price / book
- 0.06
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 29.50%
- Free cash flow
- -1.22M
- Total cash
- 12.07M
- Total debt
- 3.70M
- Return on equity
- -21.65%
- Short % of float
- 1.84%
- 50-day average
- 0.47092
- 200-day average
- 0.939895
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
About China SXT Pharmaceuticals, Inc.
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- China
- Website
- sxtchina.com
News
China SXT Pharmaceuticals Announces 1-For-100 Reverse Stock Split, Effective Oct. 26 
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
China SXT Pharmaceuticals, Inc. Announces Share Consolidation 
12 Health Care Stocks Moving In Wednesday's After-Market Session 
China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right - 12 Health Care Stocks Moving In Tuesday's Intraday Session
Dow Gains Over 200 Points; GE Aerospace Posts Upbeat Earnings - 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Why 3M Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - 12 Health Care Stocks Moving In Monday's After-Market Session
Your note
Sign in to keep a note on SXTC — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Baader Bank Aktiengesellschaft | 0.37% | 15,161 | 5.26K | Sep 29, 2024 |
| Gsa Capital Partners Llp | 0.30% | 12,300 | 4.26K | Sep 29, 2024 |
| Bank of Montreal /CAN/ | 0.25% | 10,000 | 3.47K | Sep 29, 2024 |
| UBS Group AG | 0.21% | 8,678 | 3.01K | Sep 29, 2024 |
| JP Morgan Chase & Company | 0.01% | 376 | 130 | Sep 29, 2024 |
| Acadian Asset Management. LLC | 0.01% | 379 | 131 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.00% | 54 | 18 | Oct 30, 2023 |